Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2.
about
Role of the lesion scar in the response to damage and repair of the central nervous systemThe effect of antibodies to TGF-beta1 and TGF-beta2 at a site of sciatic nerve repairProteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-beta(1) and interferon-gammaEcrg4 expression and its product augurin in the choroid plexus: impact on fetal brain development, cerebrospinal fluid homeostasis and neuroprogenitor cell response to CNS injuryIncreased adenine nucleotide translocator 1 in reactive astrocytes facilitates glutamate transport.Modulating astrogliosis after neurotrauma.Decorin treatment of spinal cord injuryGM-CSF reduces expression of chondroitin sulfate proteoglycan (CSPG) core proteins in TGF-β-treated primary astrocytes.Smad proteins differentially regulate transforming growth factor-β-mediated induction of chondroitin sulfate proteoglycansPositively Charged Oligo[Poly(Ethylene Glycol) Fumarate] Scaffold Implantation Results in a Permissive Lesion Environment after Spinal Cord Injury in RatCol1a1+ perivascular cells in the brain are a source of retinoic acid following strokeRoles of chondroitin sulfate and dermatan sulfate in the formation of a lesion scar and axonal regeneration after traumatic injury of the mouse brain.Gene transfer mediated by stem cell grafts to treat CNS injury.Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects.Should losartan be administered following brain injury?Transcriptional profiling of spinal cord injury-induced central neuropathic pain.Reduction in CNS scar formation without concomitant increase in axon regeneration following treatment of adult rat brain with a combination of antibodies to TGFbeta1 and beta2.Non-invasive detection of spatio-temporal activation of SBE and NFAT5 promoters in transgenic reporter mice following stroke.Exploring Optic Nerve Axon Regeneration.Fibronectin and laminin elicit differential behaviors from SH-SY5Y growth cones contacting inhibitory chondroitin sulfate proteoglycans.Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries.Mechanisms of hydrocephalus after intraventricular haemorrhage in adultsThe Regulatory Effects of Transforming Growth Factor-β on Nerve Regeneration.Decorin prevents the development of juvenile communicating hydrocephalus.Lesion-associated expression of transforming growth factor-beta-2 in the rat nervous system: evidence for down-regulating the phagocytic activity of microglia and macrophages.Accelerated glial reactivity to stroke in aged rats correlates with reduced functional recovery.Differential expression of fibroblast growth factor-2 and fibroblast growth factor receptor 1 in a scarring and nonscarring model of CNS injury in the rat.Decorin and colchicine as potential treatments for post-haemorrhagic ventricular dilatation in a neonatal rat model.Activation of ionotropic glutamate receptors reduces the production of transforming growth factor-beta2 by developing neurons.Ischaemia-reperfusion modulates inflammation and fibrosis of skeletal muscle after contusion injury.Small molecule inhibitor of type I transforming growth factor-β receptor kinase ameliorates the inhibitory milieu in injured brain and promotes regeneration of nigrostriatal dopaminergic axons.
P2860
Q26999096-BD572A7A-5979-468D-B754-118BFCE765C3Q28569911-F0B1109E-DA7C-4260-959C-D1212B3EAAE8Q28574893-764D018D-0C2A-4651-9E51-DDAB534F3DA0Q30274642-4D0FD6CD-24F9-40C7-80E3-89642C55056CQ33649491-40991355-F5BE-49A5-B686-B798AF39E2A9Q33932644-C5FF217A-DE13-4946-ABFF-52F8C00D3A66Q34412717-228F4861-AF94-4F24-BECF-3FE3C45777D9Q35134411-97AFC559-3003-4C20-A167-7C7FFF4F7A7CQ35401997-4777B0E7-7E85-4E0B-9911-7482C2BAFDA5Q35865332-15920A9B-25EE-4F5B-8F5B-08F925465B64Q36079004-AD22FB9F-8760-493D-9C6E-9D0F376D53B9Q36968383-01D84199-E91F-4F45-BF84-B22F8BFDD112Q37948144-0561FB24-D38A-4E9E-9FF0-A2649E373019Q38017625-E34B1296-682B-4C72-BB8C-48FA7AC41414Q38262865-1396BFE2-DDE8-4CD8-A9F2-0AF55019C9E0Q38320057-7E4A96E7-6986-4231-8994-1A66FA0D6CCBQ38523313-66B3DE86-F51A-4755-BF01-3FD2CD64FE8AQ38712429-CFFF5805-56EC-4EAB-A671-2B19AB1F39B7Q38777316-266ABE1C-221F-47BA-94D6-24EF86313FF5Q39122418-A643512F-112F-41AA-8F9F-4505E66B5A4DQ40525427-C8D339BD-299D-4BC6-96F2-78B38205DFE7Q41678770-9717D860-3DF5-4364-8842-65993C8B5625Q47133908-CD82CFC5-3AB7-42FB-B2E5-789EB8A376B9Q47684656-28DED02D-0DF8-4660-BA9A-075AC4E45A9AQ48007027-DFC26ECF-276A-4311-95CE-0AC24321D631Q48261980-2FFC7CF8-73CB-486E-8766-4CFFE2253A55Q49043794-98A5C1EE-1CD5-4D48-9F7F-B6A29AB65211Q49131837-FA78EF00-6247-4886-A95C-3BF857F923D8Q49143977-C92F7C9F-B38F-4CE5-8738-F2DBE93164CFQ50581803-F3F8F737-DE32-49A2-AC76-9B70EFB229C0Q51890656-A03C8E8A-90D2-4B6E-83A7-A7965D4544EF
P2860
Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Inhibition of glial scarring i ...... nsforming growth factor-beta2.
@ast
Inhibition of glial scarring i ...... nsforming growth factor-beta2.
@en
type
label
Inhibition of glial scarring i ...... nsforming growth factor-beta2.
@ast
Inhibition of glial scarring i ...... nsforming growth factor-beta2.
@en
prefLabel
Inhibition of glial scarring i ...... nsforming growth factor-beta2.
@ast
Inhibition of glial scarring i ...... nsforming growth factor-beta2.
@en
P2093
P2860
P1476
Inhibition of glial scarring i ...... nsforming growth factor-beta2.
@en
P2093
P2860
P304
P356
10.1046/J.1460-9568.1999.00654.X
P407
P577
1999-07-01T00:00:00Z